**Core Concept**
The question is testing the understanding of the genetic mechanism of carcinogenesis, specifically the role of tumor suppressor genes in cancer development. The Rb gene is a classic example of a tumor suppressor gene that regulates cell cycle progression.

**Why the Correct Answer is Right**
The Rb gene encodes a protein that binds to and inhibits the E2F transcription factor, which is involved in cell cycle progression. Loss of Rb function leads to uncontrolled cell proliferation. The presence of a germline mutation in one allele of the Rb gene means that the remaining allele is still functional. However, the mutation in one allele is sufficient to compromise the function of the Rb protein, leading to the development of retinal tumors. This is an example of the "two-hit hypothesis" of tumor suppressor gene inactivation, where the first hit is the germline mutation and the second hit is the loss of the remaining allele.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the question, as it does not describe a genetic mechanism of carcinogenesis.

**Option B:** This option describes a frameshift mutation, which is a type of point mutation that can lead to a premature stop codon and a truncated protein. However, it does not explain the mechanism of carcinogenesis in this patient.

**Option C:** This option describes a loss of heterozygosity, which is a common mechanism of tumor suppressor gene inactivation in cancer. However, it is not the correct answer in this case, as the patient has a germline mutation in one allele of the Rb gene.

**Clinical Pearl / High-Yield Fact**
The two-hit hypothesis of tumor suppressor gene inactivation is a key concept in understanding the genetic mechanism of carcinogenesis. Loss of function of tumor suppressor genes, such as Rb, is a common mechanism of cancer development.

**Correct Answer: C. Loss of heterozygosity is not the correct answer as the patient has a germline mutation in one allele of the Rb gene, but it is an important concept in cancer genetics.